Potent HIV-1 protease inhibitors with antiviral activities in vitro
- PMID: 2025263
- DOI: 10.1016/0006-291x(91)91652-s
Potent HIV-1 protease inhibitors with antiviral activities in vitro
Abstract
A series of novel difluoroketones with low molecular weight (less than 600 m.u.) and which are potent inhibitors of the HIV-1 protease (IC50 = 1.0 to 21 nM) were synthesized. These compounds also exhibited antiviral activity by inhibition of the cytopathic effect of HIV-1(3)B in MT-4 cells in vitro.
Similar articles
-
Pseudo-symmetrical difluoroketones. Highly potent and specific inhibitors of HIV-1 protease.FEBS Lett. 1993 Aug 23;329(1-2):144-6. doi: 10.1016/0014-5793(93)80211-c. FEBS Lett. 1993. PMID: 8354389
-
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.J Med Chem. 1992 Jul 10;35(14):2525-33. doi: 10.1021/jm00092a002. J Med Chem. 1992. PMID: 1635054
-
Difluoroketones as inhibitors of matrix metalloprotease-13.Bioorg Med Chem Lett. 2000 Jul 17;10(14):1581-4. doi: 10.1016/s0960-894x(00)00287-0. Bioorg Med Chem Lett. 2000. PMID: 10915056
-
Viral proteases as targets for chemotherapeutic intervention.Curr Opin Biotechnol. 1992 Dec;3(6):643-9. doi: 10.1016/0958-1669(92)90010-g. Curr Opin Biotechnol. 1992. PMID: 1369416 Free PMC article. Review.
-
HIV-1 protease as a potential target for anti-AIDS therapy.Ann N Y Acad Sci. 1990;616:41-53. doi: 10.1111/j.1749-6632.1990.tb17826.x. Ann N Y Acad Sci. 1990. PMID: 2078031 Review. No abstract available.
Cited by
-
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.Antimicrob Agents Chemother. 1993 Dec;37(12):2606-11. doi: 10.1128/AAC.37.12.2606. Antimicrob Agents Chemother. 1993. PMID: 8109924 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources